Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 94.10 Delayed Data As of Jun 08 |  +0.49 / +0.52%Today’s Change | 18.47 Today|||52-Week Range 106.69 | +147.70% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 50.3M | 49.9M | 48.1M | 53.6M | |
| Depreciation And Amortization | 1.8M | 682.0K | 437.0K | 431.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 48.8M | 56.1M | 94.5M | 130.0M | ||
| Research And Development | 35.1M | 39.5M | 71.3M | 97.3M | ||
| Total Operating Expenses | 50.7M | 56.7M | 95.0M | 130.5M | ||
| Non-Operating Expenses | Operating Income | -334.0K | -6.9M | -46.9M | -76.9M | |
| Extraordinary Charge | 0.00 | 0.00 | 0.00 | -1.0M | ||
| Interest Expense On Debt | -- | 0.00 | 1.5M | 6.2M | ||
| Other Expenses | 0.00 | 0.00 | -3.0K | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -302.0K | -6.7M | -47.7M | -80.5M | |
| Income Taxes | -1.1M | -441.0K | -3.0K | -26.0K | ||
| Net Income | -1.5M | -6.2M | -47.7M | -80.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 22.3M | 19.8M | 23.9M | 27.7M | |
| Shares To Calculate EPS Diluted | 22.3M | 19.8M | 23.9M | 27.7M | ||
| Earnings Per Share | EPS | -$0.07 | -$0.31 | -$1.99 | -$2.91 | |
| EPS Diluted | -$0.07 | -$0.31 | -$1.99 | -$2.91 | ||
